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Edited by Robert B. RussellAbstract In this investigation, the antibacterial modes of action
of Radix Tinosporae, its major single components, and nine anti-
biotics with diﬀerent targets or modes-of-action on Staphylococ-
cus aureus were studied. Metabolic proﬁles of cultures treated
with diﬀerent medicines were acquired by HPLC/ESI-MS. After
HPLC-MS data pretreatment, those proﬁles acquired were
reduced into several MS vectors. Then statistical processing by
principal components analysis was carried out upon those vec-
tors, two conclusions could be drawn: (1) the antibacterial mode
of action of Radix Tinosporae is similar to that of rifampicin and
norﬂoxacin, which act on nucleic acid; (2) its active components
playing main antimicrobial roles on Staphylococcus aureus
might be alkaloids, such as palmatine and jatrorrhizine.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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of action; Metabolic proﬁles; Principal component analysis1. Introduction
Tinospora capillipes Gagnep, a member of the Menisperma-
ceae family, is a special plant native in South China. Its rhi-
zome (Radix Tinosporae, R.T.) has been used in traditional
Chinese medicine (TCM) for thousands of years. The book
Gang mu shi yi [1] recorded it could detoxify arsenous oxide.
The book Guangxi traditional medicine [2] tells that R.T. could
cure gastroenteritis and remit stomach ache. The folk medicine
used it in the treatment of bacillary dysentery, and also used it
as an anticarcinogen. However, the mechanism is unknown,
which poses challenges to the pharmaceutical and agrochemi-
cal industries [3–5]. Nowadays, high-throughput methods,
such as metabonomics, are introduced to solve this problem
[6–8]. Metabonomics is an emerging analytical technology
[9], which represents the end of ‘omics’ hierarchy [10]. It is
deﬁned as a system approach to investigate the metabolic con-
sequences of patho-physiological or genetic modiﬁcation in a
multivariate and dynamic manner [11]. A ‘metabolic proﬁle’
is derived from a series of speciﬁc analytical tests run in com-
bination and used as a diagnostic aid [12]. The metabolic pro-
ﬁle could provide some useful information about metabolism
and mechanism of action [13].*Corresponding author. Fax: +86 731 882 5637.
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doi:10.1016/j.febslet.2007.07.056In this paper, with a view to investigating the antibacterial
mode of action of R.T., Staphylococcus aureus (S. aureus)
was selected as our research target, in respect that it is not only
a typical Gram-positive coccus but also a common medicinal
coccus [14].
The metabolic proﬁles of the S. aureus cultures treated with
R.T., its major chemical components (columbin, palmatine,
tinoside, and jatrorrhizine), and nine kinds of antibiotics
(Table 1), were obtained by using HPLC/ESI-MS. After data
pretreatment, those proﬁles acquired were reduced into several
MS vectors containing 950 m/z values. Principle component
analysis (PCA) was performed on those vectors. With the help
of this approach, we try to investigate the antibacterial mode
of R.T. and to identify its active components, using S. aureus
as target.2. Materials and methods
2.1. Chemicals
All authentic reference compounds (columbin, palmatine, tinoside,
jatrorrhizine, chloromycetin, streptomycin, acheomycin, rifampicin,
cefataxime, vancomycin, norﬂoxacin, erythromycin, and lincolmensin
standards) were purchased from National Institute for the Control
of Pharmaceutical and Biological Products (China). Chloroform, n-
hexane, acetone, and ethanol were of analytical grade obtained from
Merck (Darmstadt, Germany). Methanol and acetonitrile were
HPLC-grade obtained from SDS (Peypin, France). Ultrapure water
was generated by the Milli-Q system (Millipore, Bedford, MA, USA).
2.2. Extracting diﬀerent apolar parts in R.T
The dried material (10 g) was pulverized ﬁnely and passed through
an 80 mesh sieve, and then placed in a Soxhlet extraction apparatus.
The material was reﬂuxed with 100 mL of ethanol–water (95:5 v:v)
for 24 h. The ethanol and water were removed from the extracted by
evaporation at a temperature not exceeding 60 C. The residue (I)
was sequentially extracted by 20 mL n-hexane, 20 mL chloroform,
and 20 mL acetone. After volatilization of each of the solvent (the
obtained residues are named as II, III, IV in extracted order), I, II,
III, and IV were redissolved in methanol and stored at 0 C until use.
2.3. HPLC conditions
For identiﬁcation of the major components in R.T., their retention
times were compared with those of the authentic standards (columbin,
palmatine, tinoside, and jatrorrhizine).
A reversed-phase high performance liquid chromatography system
(RP-HPLC, HP 1100, Agilent) with a photodiode array detector was
used. A C18 column (Waters Symmetry C18, 150 · 3.9 mm, 5 lm)
was used for the stationary phase at 40 C with a ﬂow of
1.0 mL min1. The mobile phase consisted of (A) water and (B) aceto-
nitrile, was ﬁrst ﬁltered through a membrane of 0.22 lm, and then de-
gassed ultrasonically. The mobile phase underwent a gradient elution
procedure of 20% B in 10 min, 20–50% B in 15 min, 50–60% B inblished by Elsevier B.V. All rights reserved.
Table 1
Modes of actions of selected known antibiotics
Drug/class Function inhibited Molecular target
Chloromycetin Protein synthesis 50S ribosomal subunit
Streptomycin Protein synthesis 30S ribosomal subunit
Acheomycin Protein synthesis 30S ribosomal subunit
Erythromycin Protein synthesis 50S ribosomal subunit
Lincolmensin Protein synthesis 50S ribosomal subunit
Norﬂoxacin DNA replication/
transcription
Gyrase and topoisomerase
IV
Rifampicin Transcription RNA polymerase
Cefataxime Peptidoglycan
synthesis
Transpeptidases and
carboxpeptidases
Vancomycin Peptidoglycan
synthesis
Cell wall peptidoglycan
4180 Y. Yu et al. / FEBS Letters 581 (2007) 4179–418310 min, 60–80% B in 10 min, 80% B in 5 min. The injected volume was
20 lL.
2.4. Bacterial strains and growth conditions
S. aureus CCTCC AB9105 was used in this study. All tests were
performed in Mueller–Hinton broth (MHB). The growth of microbe
culture was monitored by measuring optical density at 600 nm in a
UV–Visible spectrophotometer.
Microbe strain was cultured into 50 mL of MHB, and incubated in a
shaker incubator overnight at 37 C. The overnight culture was diluted
to a concentration of approximately 108 cfu mL1 and used as the
source of inoculums. Solutions of each drug and apolar extract were
prepared with concentration ranging from 1.25 to 80000 lg mL1.
100 lL of the coccus inoculum was re-inoculated into MHB containing
diﬀerent concentrations of each drug (Table 2). The culture was again
incubated overnight with shaking at 37 C. The inhibition of each drug
and apolar extract to cells growth was between the approximate ranges
of 40–80% to ensure that any change in the metabolic proﬁles could be
ascribed to the mode of action of the inhibitor and not changes in
growth rate [15].
2.5. Extracting of metabolites from Staphylococcus aureus
Approximately 24 h after inoculation, when the majority of culture
appeared to have entered stationary phase, samples of culture (5 mL)
were quickly harvested with a 5 ml automate Gilson pipette and
released into 20 ml methanol–water solution (60% v:v) at 40 C,
resulting in a ﬁnal methanol concentration of 50% (v:v) after quench-Table 2
Concentrations of antibiotics, extracts of Radix Tinosporae (I–IV) and
reference compounds used in the inoculation of individual samples/
cultures of S. aureus
Drugs used Concentration (lg mL1) Sample symbolsa
Controls
Acheomycin 0.25, 0.125
Lincolmensin 16, 8
Erythromycin 2, 1
Chloromycetin 8, 4
Streptomycin 16, 8
Cefataxime 0.25, 0.125
Vancomycin 0.5, 0.25
Rifampicin 4, 2 n
Norﬂoxacin 4, 2 h
I 1500, 750 e
IV 500, 250 
II 8000, 4000
III 3000, 1500
Columbin 8000, 4000
Tinoside 2000, 1000
Palmatine 400, 200 /
Jatrorrhizine 400, 200 +
The sample symbols refer to the individual MS vectors proﬁles rep-
resented as points in PCA projections.
aFor interpretation of color in Table 2, the reader is referred to the web
version of this article.ing. The samples were carefully released into the centre of the metha-
nol solution to avoid freezing on the sides of the tubes. The biomass
was separated from the quenching solution by centrifugation at
1000 rpm (relative centrifugal force 770 · g) for 20 min at 20 C. After
that, the pellet was resuspended in 10 mL cold (40 C) absolute meth-
anol in a tube. Following rapid mixing, the tube was transferred into
dry ice for 30 min, then thawed in an ice bath for 10 min and centri-
fuged (12000 rpm for 10 min at 4 C, Relative centrifugal force
8000 · g). The supernatant was transferred to a new tube. To the
extracted pellet, cold (40 C) methanol–water (50:50 v:v) was added
to extract any metabolites left after the ﬁrst extraction. The ﬁrst and
the second extracts were combined and concentrated for 6 h in vacuum
at 4 C [16]. The samples were stored at 40 C until LC/ESI-MS anal-
ysis. This was done on every batch of culture with nine antibiotics,
R.T. extracted by ethanol (I), diﬀerent apolar parts in R.T. (II, III,
IV), and the diﬀerent components in R.T. (columbin, palmatine, tino-
side, and jatrorrhizine).
2.6. HPLC/ESI-MS conditions
A Shimadzu LC system, consisting of a Shimadzu (Kyoto, Japan)
LC-10ADvp solvent delivery pump, an FCV-10ALvp low pressure
gradient unit, a DGU-14A degasser, a CTO-10Avp column oven, a
SPD-M10Avp photodiode array detector, a 8125 Rheodyne manual
injector (CA, USA), coupled to a LCMS-2010 single quadrupole
equipped with electrospray ionization (ESI) probe were used in this
study. The temperatures were maintained at 250, 250, 200 C for the
probe, CDL and block, respectively. The voltages were set at 4.5 kV,
30 V, 25 V, 150 V and 1.5 kV for the probe, CDL, Q-array 1, 2, 3
bias, Q-array RF and detector, respectively. The ﬂow rate of nebulizer
gas was 4.5 L min1. The ions of selection monitoring were decided by
positive scanning from m/z 100–1500. The separation was performed
on a C18 (Thermo Hypersil-Keystone Hypurity, 150 mm · 2.1 mm,
5 lm) analytical column, and the oven temperature was set at 40 C.
The mobile phase, consisting of (A) water and (B) methanol (contain-
ing 0.2% formic acid), was ﬁrst ﬁltered through a membrane of
0.22 lm and degassed ultrasonically. The mobile phase underwent a
gradient elution procedure of 5–28% B in 20 min, 28–55% B in 20–
30 min, 55–72% B in 30–50 min, 72–85% B in 50–70 min, 85–90% B
in 70–90 min, 90–85% B in 90–110 min, 85–5% B in 110–140 min.
The ﬂow-rate was set at 0.2 mL min1. The injected volume is 5 lL.
The data were collected and processed using LC/MS Solution software
2.02.
2.7. Principle component analysis and pretreatment of data
PCA, which has been widely used for exploratory data analysis
[17,18], may be a useful and convenient means for possible evaluation
of modes of action. In this investigation, PCA was used to explore the
intrinsic relationship between R.T. and nine kinds of antibiotics.
The data of spectrochromatograms for each sample at the deter-
mined retention time from 0 to 90 min (see supporting information)
was picked up to perform PCA. Before PCA, a data pretreatment is
necessary. Each ESI-MS array was reduced into a single ‘aggregate’
MS vector by summing the ion counts of a given m/z ratio over the
total scan cycle. Thus, after this initial data reduction an ESI-MS
spectrochromatogram with MS range 50–1000 m/z will be reduced to
a single vector having 950 values [19]. The m/z proﬁles of all samples
obtained after preprocessing were shown as supporting information
as well. Then PCA was performed on the MS matrixes obtained.
The loadings plots for the PCA analyses were provided as supporting
information. All programs were coded in MATLAB 6.5 for windows.3. Results and discussion
3.1. The major chemical components in R.T.
Typical HPLC proﬁles of samples I, II, III, and IV are
shown in Fig. 3. Compared Fig. 1b, c, d with Fig. 1a, we ﬁnd
that the extracts of n-hexane (II), chloroform (III), and acetone
(IV) contained all main chemical components in R.T. (I)
(Fig. 1a). Comparing the retention times and UV spectra with
those of the authentic standards, the ester, columbin, was the
major constituent in the n-hexane extract (II), the glycoside,
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Fig. 1. HPLC proﬁles (detection method: DAD-UV, 254 nm) of I (Radix tinosporae extracted into ethanol). (a) HPLC proﬁles (detection method:
DAD-UV, 254 nm) of IV (Radix tinosporae extracted into acetone). (b) HPLC proﬁles (detection method: DAD-UV, 254 nm) of II (Radix
tinosporae extracted into n-hexane). (c) HPLC proﬁles (detection method: DAD-UV, 254 nm) of III (Radix tinosporae extracted into chloroform)(d).
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palmatine and jatrorrhizine, in the acetone extract (IV)
(Fig. 1).
3.2. Antibacterial mode of action of R.T. and the major
antimicrobial components
Fig. 2 depicts the MS vectors proﬁles of controls, cultures
treated with norﬂoxacin and cultures treated with vancomycin.50 150 250 350 450
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Fig. 2. Typical MS vectors proﬁles of controls (1), cultures treatedThe obvious diﬀerences could be found between these proﬁles,
hence, allowing the classiﬁcation of drugs according to their
MS vectors proﬁles.
The PCA projection plots of all MS vectors proﬁles acquired
(including control samples, the samples treated with I (e),the
extracts II ( ), the extracts III ( ),the extracts IV (s), colum-
bin ( ), tinoside ( ), palmatine (/), jatrorrhizine (+), and nine
antibiotics) are shown in Fig. 3. One could see clearly that the550 650 750 850 950
1
2
3
m/z
with norﬂoxacin (2), cultures treated with vancomycin (3).
Fig. 3. PCA projection of the MS vectors proﬁles of controls and
cultures treated with Radix Tinosporae (I), extracts (II, III, and IV),
columbin, palmatine, tinoside, jatrorrhizine, nine antibiotics. [controls
( ), acheomycin ( ), lincolmensin ( ), erythromycin ( ), chloro-
mycetin ( ), streptomycin ( ), cefataxime ( ), vancomycin ( ),
rifampicin (n), norﬂoxacin (h), I (r), II ( ), III ( ), IV (s), columbin
( ), tinoside ( ), palmatine (/), jatrorrhizine (+)].
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though no two drugs produce exactly the same pattern of load-
ings. It should be pointed out that in the proﬁles either dose of
drugs-treatment clusters together. Thus, a conclusion could be
drawn that the diﬀerence between two doses of each drug is lit-
tle in our investigation. Generally, the cultures treated with
drugs of similar targets cluster together, at both treatment con-
centrations, and that those of diﬀerent targets are distinguish-
able from each other in PCA projections (Fig. 3). For instance,
cefataxime ( ) whose target is on transpeptidases and carbox-
peptidases, at both dose concentrations, formed a distinct clus-
ter separate from the other antibiotics based on its diﬀerent
mode of action. Likewise, vancomycin ( , at both dose
groups), whose target is on cell wall peptidoglycan, clustered
separately as a group. Similarities in patterns are apparent
among classes of drugs that aﬀected the same site [20]. As we
know from Table 1, lincolmensin, erythromycin and chloro-
mycetin have eﬀects on 50S ribosomal subunit, and streptomy-
cin and acheomycin act on 30S ribosomal subunit. In the
projection plot (Fig. 3), one could see that the points of acheo-
mycin ( ) and streptomycin ( ) cluster together, lincolmensin
( ), erythromycin ( ) and chloromycetin ( ) cluster together
as well. The results of PCA support the hypothesis that modes
of actions of a drug could be identiﬁed by the metabolic pro-
ﬁles acquired. This may provide the basis to classify the meta-
bolic proﬁles by PCA and to ﬁnd out the possible mode of
action of TCM.
It is interesting that rifampicin (n), norﬂoxacin (h) and R.T.
(e) cluster together. The targets of rifampicin and norﬂoxacin
are on RNA polymerase, gyrase and topoisomerase IV.
According to the principle of PCA, the mode of action of
R.T. on S.aureus is therefore expected to be similar to rifampi-
cin and norﬂoxacin. It may imply that the target of R.T. pos-
sibly is nucleic acid. The results from this ﬁgure are consistent
with Table 1.
Moreover, from Fig. 3, one can clearly see that the points of
the extracts III ( ) and tinoside ( ), the main component in
III, are clustered as a single group, which distinguishes from
any classiﬁcation presented. This hints that the extracts IIIand tinoside have the similar mode of action, which is diﬀerent
from the mode of other drugs studied in this investigation. In
the same way, the points representing the extracts II ( ) and it
major compound columbin ( ) forms a single group, which
means their mode are diﬀerent with others. However, the
points representing the proﬁles from the extracts IV () were
close to that of the extracts of R.T. (I) (e). An interesting
observation was made with the points representing the proﬁles
of palmatine (/) and jatrorrhizine (+), which are both compo-
nents of the extracts IV, as they clustered close to those repre-
senting the extracts of R.T. (I, e). This ﬁnding implies that
palmatine and jatrorrhizine, and possibly the components in
IV, show a similar mode of action on S. aureus as the extracts
of R.T. (I). It could be hypothesized that the synergistic action
of alkaloids in R.T., rather than a single component, contrib-
utes to the main antimicrobial action on S. aureus.4. Conclusion
In this paper, the MS vectors proﬁles of diﬀerent cultures
coccus treated by diﬀerent antibiotics and by diﬀerent extracts
of R.T. were explored with the help of PCA in order to inves-
tigate the mode of action and to identify the main antimicro-
bial components of the R.T., based on comparison of the
known modes of actions of several diﬀerent antibiotics.
Although the method is immature, the results obtained in this
investigation provide some insight into the mode of action and
possible mechanism of the compound under investigation.
Further research will be required to validate the extract mech-
anism of this compound.
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